The 12th Vail 2024: Hot Topics in Radiology: Advanced Applications and Artificial Intelligence

Feb 10th, 2024Feb 15th, 2024
Vail, CO
US
https://edusymp.com/product/details/1574
Phone:813-806-1000
Join us in person in Vail, CO, or register for the live webcast if you cannot attend in person.
Latest in Conference
A Ibrain
PET reveals brain receptor deficits in schizophrenia
June 4, 2026
Webinar: AI for CT & PET/CT Imaging
Sponsored
Webinar: AI for CT & PET/CT Imaging
June 4, 2026
Asco Thumb
ASCO: With help from AI, interventions boost lung cancer screening
June 3, 2026
Representative SV2A PET images comparing synaptic density in healthy and disease states. The left panel shows F-18 SynVesT-1 PET distribution volume (VT) maps of the brain and spinal cord in a naïve control mouse and a mouse with experimental autoimmune encephalomyelitis (EAE), a model of multiple sclerosis. The right panel shows Cu-11 UCB-J PET images of the brain of a 46-year-old male healthy control (left) and 43-year-old female MS patient (right).
SNMMI: PET reveals new brain activity in multiple sclerosis
June 2, 2026
Related Stories
2010 03 07 11 49 45 24 Ferrari thumb
CT
One-day bowel prep eases VC for patients, providers
2010 03 05 11 30 50 954 Sonalleve Philips Ecr 250
Nuclear Medicine
PET/MRI suite paces Philips ECR news
2009 12 03 15 27 30 887 Singh thumb 12 09
CT
ASIR cuts dose in Crohn's disease patients
Webinar: AI for CT & PET/CT Imaging
Sponsor Content
Webinar: AI for CT & PET/CT Imaging
More in Conference
PET reveals brain receptor deficits in schizophrenia
By Will Morton
The study confirms that deficits in M1 receptor are present in a subgroup of schizophrenia patients.
June 4, 2026
A Ibrain
AI-driven cardiac PET attenuation correction shows promise
By Kate Madden Yee
The algorithm could offer a “practical alternative in cardiac PET,” researchers noted.
June 3, 2026
Cardiac stress test imaging comparison showing DeepAC and CT-based attenuation correction scans for two patients with quantitative perfusion data.
ASCO: With help from AI, interventions boost lung cancer screening
By Erik L. Ridley
Screening rate increased sharply over six years at the 17-hospital health system.
June 3, 2026
Asco Thumb
SNMMI: PET reveals new brain activity in multiple sclerosis
By Will Morton
Understanding how and where certain brain connections are lost can help explain the symptoms patients experience.
June 2, 2026
Representative SV2A PET images comparing synaptic density in healthy and disease states. The left panel shows F-18 SynVesT-1 PET distribution volume (VT) maps of the brain and spinal cord in a naïve control mouse and a mouse with experimental autoimmune encephalomyelitis (EAE), a model of multiple sclerosis. The right panel shows Cu-11 UCB-J PET images of the brain of a 46-year-old male healthy control (left) and 43-year-old female MS patient (right).
SNMMI: New PET platform guides real-time bone cancer margin assessment
By Kate Madden Yee
The approach has the potential to reshape surgical practice for osteosarcoma by allowing for precise tumor resection.
June 2, 2026
(A-C) Representative whole-body maximum-intensity projection images and regional fused PET/CT images from three histologically confirmed osteosarcoma patients who underwent paired [68Ga]Ga-B7-H3-BCH PET/CT and 18F-FDGE PET/CT within seven days. (D) Multimodal imaging evaluation of Patient Three, including x-ray, MRI (T2-weighted imaging, T2WI), CT, and B7-H3 PET/CT.
SNMMI names officers for 2026–2027 term
By AuntMinnie.com staff writers
Society of Nuclear Medicine and Molecular Imaging leaders take office.
June 2, 2026
Snmmi Thumb 3m Ipa Ljl Nl
SNMMI: Incoming president talks meeting highlights, previews next year
By Kate Madden Yee
AuntMinnie.com interviewed incoming SNMMI president Heather Jacene, MD.
June 2, 2026
Heather Jacene, MD
SNMMI: Biomarkers predict I-131 response in obese thyroid cancer patients
By Kate Madden Yee
Metabolic status should be considered in post-therapy evaluation of obese differentiated thyroid cancer patients, researchers noted.
June 2, 2026
Snmmi Thumb
SNMMI: Theranostic approach may treat PSMA-negative prostate cancer
By Amerigo Allegretto
A theranostic approach could help improve PET imaging for neuroendocrine prostate cancer care.
June 2, 2026
RET-targeted PET tracer highlights neuroendocrine prostate cancer tumors. Representative PET imaging shows strong tumor uptake of the RET-binding peptide tracer [⁶⁸Ga]Ga-DOTA-RET-L7 in a neuroendocrine prostate cancer (NEPC) model, supporting highly specific, high-contrast detection.
ASCO: Use of GLP-1 drugs linked to lower breast cancer cases
By Erik L. Ridley
A large retrospective study found sharply lower incidence of breast cancer among women who had received GLP-1 drugs.
June 2, 2026
Asco Thumb
SNMMI: CAIX-targeted PET tracer detects clear cell renal cell carcinoma
By Liz Carey
Researchers aim for "more precise molecular map" for kidney cancer.
June 1, 2026
A 68Ga-RCC78 PET scan (C) of a patient four years post-radical right nephrectomy. During follow-up, new nodules were detected in the left adrenal gland and kidney. CAIX-targeted scan clearly visualized metastatic lesions in the mediastinum, pancreas, adrenal gland, and kidney (SUVmax > 30), demonstrating the tracer's ability to maintain high tumor uptake despite significantly reduced abdominal background.
SNMMI: Low-cost absorbents clear over 90% of Lu-177 from wastewater
By Kate Madden Yee
An increase in the use of radionuclide therapy has added burden to wastewater management systems.
June 1, 2026
Snmmi Thumb
Page 1 of 688
Next Page